TUESDAY RESIDENT SEMINARS
2006-2007
PSYCHIATRIC DISORDERS-BENCHSIDE TO BEDSIDE: UNIPOLAR DEPRESSION
9/26 Clinical Phenomenology Yvette Sheline, M.D.
10/10 Norepinephrine System Gabriel de Erausquin, M.D., Ph.D.
10/17 Treatment 1: Review of Antidepressants Eugene H. Rubin, M.D., Ph.D.
10/24 Epidemiology Jeffrey Scherrer, Ph.D.
10/31 Serotonin System Amelia Gallitano-Mendel, M.D., Ph.D.
11/7 Treatment 2: Rating scales: Practice Patient Jose Mathews, M.D.
11/14 Treatment 3: Treatment Guidelines Jose Mathews, M.D.
11/21 Treatment 4: Rx-Resistant MDD, Li augmentation Michael Jarvis, M.D., Ph.D.
11/28 Clinical Neuroscience of Depression Yvette Sheline, M.D.
12/5 Treatment 5: ECT Keith Isenberg, M.D.
12/12 Genetics 2 Laura Bierut, M.D.
12/19 Treatment 6: TMS Keith Isenberg, M.D.
12/26 Vagus Nerve Stimulation Gabriel de Erausquin, M.D., Ph.D.
EPIDEMIOLOGY
1/9 Epidemiological Methods Kathleen Bucholz, Ph.D.
1/16 Epidemiological Methods Kathleen Bucholz, Ph.D.
1/23 Epidemiological Methods Kathleen Bucholz, Ph.D.
1/30 Epidemiological Methods Kathleen Bucholz, Ph.D.
PSYCHIATRIC DISORDERS BENCHSIDE TO BEDSIDE: OCD/Panic/GAD
2/6 GABA System Steven Mennerick, Ph.D.
2/13 Phenomenology and Anatomy Elliot Nelson, M.D.
2/20 Epidemiology Elliot Nelson, M.D.
2/27 Anxiety symptoms in PD Kevin Black, M.D.
3/6 Treatment of Anxiety Disorders Michael Jarvis, M.D., Ph.D.
3/13 Genetics Elliot Nelson, M.D.
3/20 non-pharmacological (rTMS, surgery)
treatment of OCD Kevin Black, M.D.
PSYCHOLOGICAL TESTING
3/27 Assessment of Developmental Disorders Gitry Heydebrand, Ph.D.
4/3 Neuropsychological Assessment Gitry Heydebrand, Ph.D.
4/10 The Role of Testing in Psychiatric Disorders Gitry Heydebrand, Ph.D.
4/17 Personality Assessment Gitry Heydebrand, Ph.D.
PERSONALITY DISORDERS
4/24 Relevance of Personality Biology to Treatment Dragan Svrakic, M.D., Ph.D.
5/1 Genetics of Personality C. Robert Cloninger, M.D.
5/8 Endophenotypes of Somatoform and
Personality Disorders Mehmet Dokucu, M.D., Ph.D.
5/15 Biology of Personality in Relation to
understanding Psychosis and Depression C. Robert Cloninger, M.D.
|
2005-2006
Psychiatric Disorders-Benchside to Bedside: Schizophrenia
9/20 Orientation Nuri
B. Farber, M.D.
9/27 Programmed
Cell Death Steven
Mennerick, Ph.D.
10/4 Clinical
Phenomenology John
Newcomer, M.D.
10/11 Dopaminergic
System Gabriel
de Erausquin, M.D., Ph.D.
10/18 Anatomy John
Csernansky, M.D.
10/25 Epidemiology Kathleen
Bucholz, Ph.D.
11/1 Newer
Antipsychotics John
Newcomer, M.D.
11/8 Traditional
Antipsychotics and Clozapine Nuri
B. Farber, M.D.
11/15
Genetics Laura Bierut, M.D. and C. Robert Cloninger, M.D.
11/29 Adverse Events Peter Fahnestock, M.D.
12/6
Treatment of Drug Resistant Psychosis and the use of Non-Antipsychotic
Agents Dan Haupt, M.D.
EPIDEMIOLOGY
1/3 Epidemiological
Methods Kathleen
Bucholz, Ph.D.
1/11 Epidemiological
Methods Kathleen
Bucholz, Ph.D.
1/18 Epidemiological
Methods Kathleen
Bucholz, Ph.D.
1/25 Epidemiological
Methods Kathleen
Bucholz, Ph.D.
PSYCHIATRIC DISORDERS BENCHSIDE TO BEDSIDE: BIPOLAR DISORDERS
1/31 Lithium Keith
Isenberg, M.D.
27 Anticonvulsants Steven
Mennerick, Ph.D.
2/14 Phenomenology
and Anatomy Kevin
Black, M.D.
2/21 Epidemiology Elliot
Nelson, M.D.
2/28 Genetics Laura
Bierut, M.D.
3/7 Treatment of Bipolar Disorder Keith Isenberg, M.D
3/14
Treatment of Treatment-Resistant Bipolar Disorder I and Bipolar
Variants Michael Jarvis, M.D., Ph.D.
PSYCHOLOGICAL TESTING
3/21 Tests
and Suicide Richard
Wetzel, Ph.D.
3/28 The
Rorschach Procedure Gitry
Heydebrand, Ph.D.
4/4
Neuropsychological Testing and the Treatment/rehabilitation
of TBI Patients Robert Fucetola, Ph.D.
4/11 Millon
Test of Personality Richard
Wetzel, Ph.D.
PERSONALITY DISORDERS
4/18 Treatment
of Personality Disorders C.
Robert Cloninger, M.D.
4/26
Role of Personality in Treating Mood Disorders C. Robert Cloninger,
M.D.
5/2
Role of Personality in Treating Somatoform Disorders Mehmet
Dokucu, M.D., Ph.D.
5/9
Role of Personality in Treating Substance Dependence Dragan
Svrakic, M.D., Ph.D.
|
| 2004-2005 |
| PSYCHIATRY DISORDERS-BENCHSIDE TO BEDSIDE:
Dementia 9/21-12/14/04 |
| Nuri B. Farber, M.D. |
Muscarinic Cholinergic System |
| Anne Fagan Niven, Ph.D. |
Amyloid |
| Anne Fagan Niven, Ph.D. |
Animal Models |
| Steven Mennerick, Ph.D. |
Glutamate System |
| Alison Goate, D.Phil. |
Genetics and Epidemiology of AD and other Dementias |
| Martha Storandt, Ph.D. |
Psychometrics and Dementia |
| James Galvin, M.D. |
AD and Other Dementias, Diagnosis & Differential Diagnosis |
| Daniel McKeel, M.D. |
Anatomy of Dementias |
| Keith Garcia, M.D., Ph.D. |
Prions, Huntington's Disease, etc. |
| John Morris, M.D. |
Healthy Aging, Early Impairment, Evaluations, Rating Scales |
| John Csernansky, M.D. |
Imaging |
| Eugene H. Rubin, M.D., Ph.D. |
Pathophysiology and Treatment of AD |
| Nuri B. Farber, M.D. |
Psychosis/Agitation in AD and its Treatment |
|
|
| EPIDEMIOLOGY 1/4-1/25/05 |
| Kathleen Bucholz, Ph.D.
|
Epidemiologic Methods |
| Kathleen Bucholz, Ph.D. |
Epidemiologic Methods II |
| Kathleen Bucholz, Ph.D. |
Epidemiologic Methods III |
| Anne Glowinski, M.D. |
Child Assessment |
| |
|
|
| PSYCHIATRY DISORDERS-BENCHSIDE TO BEDSIDE:Substance
Abuse 2/1-3/8/05 |
| Mehmet Dokucu, M.D., Ph.D. |
Opiate System |
| Gabriel de Erausquin, M.D., Ph.D. |
Dopamine and the Reward System |
| Amelia Gallitano-Mendel, M.D., Ph.D. |
Nicotinic Cholinergic System |
| Danielle Dick, Ph.D. |
Alcoholism Genetics & Epidemiology |
Pamela Madden, Ph.D.
Andrew Heath, D.Phil. |
Substance Abuse Genetics & Epidemiology |
| Dragan Svrakic, M.D., Ph.D. |
Treatment of Nicotine, EtOH & Opiate Dependence |
|
|
| PSYCHOLOGICAL TESTING 3/15
- 4/5/05 |
| Gitry Heydebrand, Ph.D. |
Neuropsychological Assessment: Dementia |
| Richard Wetzel, Ph.D. |
Validity Scales on Personality Tests |
| Richard Wetzel, Ph.D. |
PTSD and Testing |
| Richard Wetzel, Ph.D. |
Does it Matter Who Does the Testing |
|
|
| PERSONALITY DISORDERS 4/12 - 5/3/05 |
| Mehmet Dokucu, M.D., Ph.D. |
Use of DSM-IV to Assess Personality and its Disorders |
| Dragan Svrakic, M.D., Ph.D. |
How to Use the TCI to Assess Personaltiy and its Disorders |
| C. Robert Cloninger, M.D. |
Alternative Ways of Assessing Personality and its Disorders |
| C. Robert Cloninger, M.D. |
Assessing Personality as a Routine Part of the Mental Status
Examination |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WEDNESDAY ADVANCED RESIDENT COURSE SERIES
2006-2007
Cross Cultural Psychiatry - Keith Garcia, M.D., Ph.D., Coursemaster
9/27 Introduction to Cross Cultural Psychiatry Keith Garcia, M.D., Ph.D.
10/4 Introduction to Cross Cultural Psychiatry Keith Garcia, M.D., Ph.D.
10/11 Introduction to Cross Cultural Psychiatry Keith Garcia, M.D., Ph.D.
10/18 Introduction to Cross Cultural Psychiatry Keith Garcia, M.D., Ph.D.
10/25 Introduction to Cross Cultural Psychiatry Keith Garcia, M.D., Ph.D.
11/1 Introduction to Cross Cultural Psychiatry Keith Garcia, M.D., Ph.D.
Law, Ethics, and Psychiatry - Melissa Swallow, M.D., Coursemaster
11/8 Introduction/Competency/Guardianship Melissa Swallow, M.D.
11/15 Confidentiality/Privilege/Informed Consent John Rabun, M.D.
11/29 Workers’ Compensation/ADA/ERISA/
Sexual Harassment Melissa Swallow, M.D.
12/6 Duty to Protect Melissa Swallow, M.D.
12/13 Insanity Defense John Rabun, M.D.
12/20 Malingering-Psychological Testing Richard Wetzel, Ph.D.
1/10 Right to Treatment/Right to Refuse
Treatment/Civil Commitment John Rabun, M.D.
1/17 Violence Risk Assessment/Sex Offenders Melissa Swallow, M.D.
1/24 Malpractice/Ethics in Forensic Psychiatry Melissa Swallow, M.D.
John Rabun, M.D.
Family Therapy and other Psychotherapeutic Topics – Mark Johnson, M.D., Coursemaster
2/7 Family Therapy and other Psychotherapeutic Topics Mark Johnson, M.D.
2/14 Family Therapy and other Psychotherapeutic Topics Mark Johnson, M.D.
2/21 Family Therapy and other Psychotherapeutic Topics Mark Johnson, M.D.
2/28 Family Therapy and other Psychotherapeutic Topics Mark Johnson, M.D.
3/7 Family Therapy and other Psychotherapeutic Topics Mark Johnson, M.D.
3/14 Family Therapy and other Psychotherapeutic Topics Mark Johnson, M.D.
Neuroimaging/Functional Anatomy of Emotion - Kevin Black, M.D., Coursemaster
3/21 Introduction to Neuroimaging, Part I Kevin Black, M.D.
3/28 Introduction to Neuroimaging, Part II Kevin Black, M.D.
4/4 Introduction to Neuroimaging, Part III Kevin Black, M.D.
4/11 How to Read a Neuroimaging Paper Kevin Black, M.D.
4/18 Using MDD as a Paradigm to Understand Yvette Sheline, M.D.
Neuroimaging Analysis
4/25 Studying Psychopathology with Functional Imaging:
Some of the Issues Debra Gusnard, M.D.
5/2 A Computational Anatomy Approach to Measuring
Hippocampal Shape and Shape Change in Very Mild
DAT Lei Wang, Ph.D.
|
2005-2006
The Practice
of Psychiatry: Business and Administrative Aspects -
Eugene H. Rubin,, M.D., Ph.D., Coursemaster
9/21 Don’t be
a Chump: What You Need to Know about the Business of Psychiatry
Steven Harvey, M.D.
9/28 Everything You
Need to Know about Starting Your Own Practice Stacey Smith,
M.D.
10/5 Establishing
a Practice Cindy Smith and Marlene Miller
10/12 Contracting
& Credentialing Cindy Smith and Marlene Miller
10/19 Billing and
Collections Cindy Smith and Marlene Miller
10/26 Compliance
– Record and HIPAA Cindy Smith and Marlene Miller
11/2 Administrative
Psychiatry: Part I Mark Johnson, M.D.
11/9 Administrative
Psychiatry: Part I (cont.) Mark Johnson, M.D.
11/16 Practical Aspects
of Private Practice Luis Giuffra, M.D., Ph.D.
11/23 Administrative
Psychiatry: Part II Mark Johnson, M.D.
History of Psychiatry
11/30/2005-1/25/2006 - Eugene H. Rubin, M.D., Ph.D.,
Coursemaster
11/30 Organizational
Meeting and Overview Eugene Rubin, M.D., Ph.D.
Shorter Chapter 1:
The Birth of Psychiatry Sofia Yahya, M.D.
Soraya Asadi, M.D.
12/7 Shorter Chapter
2: The Asylum Era Stephanie Purcell, M.D.
Amy Walton, M.D.
12/14 Shorter Chapter
3: The First Biological Psychiatry Sanjeev Rao, M.D.
Jeffrey Vander Kooi,
M.D.
12/21 Shorter Chapter
4: Nerves Fay Womer, M.D.
Meg Corrigan, M.D.
1/4 Shorter Chapter
5: The Psychoanalytic Hiatus Michelle Nichols, M.D.
Scott Filippino,
M.D.
1/11 Shorter Chapter
6: Alternatives Anya Voeller, M.D.
Christopher Loynd,
D.O.
Afshan Sultana, M.D.
1/18 Shorter Chapter
7: Second Biological Psychiatry Ellen Edens, M.D.
Janell Standifer,
M.D.
Mina Charepoo, M.D.
1/25 Shorter Chapter
8: From Freud to Prozac George Karam, M.D.
Robert Coates, M.D.
Translational
Research and Reading the Scientific Literature 2/1-5/31/2006
– Nuri B. Farber, M.D., Coursemaster
2/1 ANOVA
Nuri B. Farber, M.D.
2/8
Drug-Induced Neurodegeneration Meg Corrigan, M.D.
Anya
Voeller, M.D.
2/15
Neurogenesis Sanjeev Rao, M.D.
2/22
Genetic Approaches Michelle Nichols, M.D.
3/1
Stress, MDD, & 5-HTTT Sofia Yahya, M.D.
3/8
Antidepressants & Neurogenesis Amy Walton, M.D.
3/15
Memory Ellen Edens, M.D.
Stephanie
Purcell, M.D.
3/22
CATIE Jeffrey Vander Kooi, M.D.
3/22
Inflammation & Hippocampal Neurogenesis Soraya Asadi, M.D.
4/5
Mood Disorders Robert Coates, M.D.
Georges
Karam, M.D.
4/12
NMDA & Schizophrenia Mina Charepoo, M.D.
Fay
Womer, M.D.
4/19
Survival Analysis Scott Filippino, M.D.
4/26
Amyloid and AD Janell Standifer, M.D.
Afshan
Sultana, M.D.
5/3
Unwanted Memories Christopher Loynd, M.D.
|
|
